by According to Precedence Research, during the forecast period of 2022 to 2030, the global ePharmacy market is estimated to develop at a compound annual growth rate (CAGR) of 17.51%. The global ePharmacy market was valued at USD 59.93 billion in 2021, and it is predicted to exceed USD 256 billion by 2030. The study investigates several elements and their consequences on the growth of the ePharmacy market.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1793
This report focuses on ePharmacy market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall ePharmacy market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.
Report Scope of the ePharmacy Market
| Report Coverage | Details |
| Market Size by 2030 | USD 256 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 17.51% |
| North America Market Share in 2021 | 41% |
| OTC Products Segment Market Share in 2021 | 70% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Type, Drug Type, Operating Platform, Platform, Payment Method, Business Model, Geography |
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
In-Depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of ePharmacy, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of ePharmacy has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the ePharmacy market.
Some of the prominent players in the ePharmacy market include:
- The Kroger Co.
- DocMorris
- Walgreen Co.
- Rowlands Pharmacy
- Giant Eagle, Inc.
- Optum Rx, Inc.
- Walmart, Inc.
- CVS Health
- Express Scripts Holding Company
- Netmeds
Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1793
Segments Covered in the Report
By Product
- Over-the-Counter (OTC) Products
- Prescription Medicine
By Type
- Analgesics
- Skin Care
- Dental
- Cold and Flu
- Vitamins & Minerals
- Weight Loss
- Other
By Drug Type
- Foam Dressings
- Film Dressings
- Hydrocolloid Dressings
- CHG Adhesive Dressings
- Alginate Dressing
- Surgical Tapes
- Hydrogel Dressings
- Collagen Dressings
- Barrier Tapes
- Tissue Sealants
- Negative Pressure Wound Therapy Drapes
- Others
By Operating Platform
- Diabetic Foot Ulcers
- Pressure Ulcers
- Surgical and Traumatic Wounds
- Burns
- Ostomy Care
- Others
By Platform
- Mobile Users
- Desktop Users
By Payment Method
- Cash on Delivery
- Online Payment
By Business Model
- Hospitals and Clinics
- Home Care Settings
- Others
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- What value propositions should businesses aim at while making new research and development funding?
- Which regulations will be most helpful for stakeholders to boost their supply chain network?
- Which regions might see the demand maturing in certain segments in near future?
- What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
- Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
- Which government regulations might challenge the status of key regional markets?
- How will the emerging political and economic scenario affect opportunities in key growth areas?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global ePharmacy Market, By Product
7.1. ePharmacy Market, by Product, 2022-2030
7.1.1. Over-the-Counter (OTC) Products
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Prescription Medicine
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global ePharmacy Market, By Type
8.1. ePharmacy Market, by Type, 2022-2030
8.1.1. Analgesics
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Skin Care
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Dental
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Cold and Flu
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Vitamins & Minerals
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Weight Loss
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Other
8.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global ePharmacy Market, By Drug Type
9.1. ePharmacy Market, by Drug Type, 2022-2030
9.1.1. Foam Dressings
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Film Dressings
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Hydrocolloid Dressings
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. CHG Adhesive Dressings
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Alginate Dressing
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Surgical Tapes
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Hydrogel Dressings
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Collagen Dressings
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.9. Barrier Tapes
9.1.9.1. Market Revenue and Forecast (2017-2030)
9.1.10. Tissue Sealants
9.1.10.1. Market Revenue and Forecast (2017-2030)
9.1.11. Negative Pressure Wound Therapy Drapes
9.1.11.1. Market Revenue and Forecast (2017-2030)
9.1.12. Others
9.1.12.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global ePharmacy Market, By Operating Platform
10.1. ePharmacy Market, by Operating Platform, 2022-2030
10.1.1. Diabetic Foot Ulcers
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Pressure Ulcers
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Surgical and Traumatic Wounds
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Burns
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Ostomy Care
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global ePharmacy Market, By Platform
11.1. ePharmacy Market, by Platform, 2022-2030
11.1.1. Mobile Users
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Desktop Users
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global ePharmacy Market, By Payment Method
12.1. ePharmacy Market, by Payment Method, 2022-2030
12.1.1. Cash on Delivery
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Online Payment
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global ePharmacy Market, By Business Model
13.1. ePharmacy Market, by Business Model, 2022-2030
13.1.1. Hospitals and Clinics
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Home Care Settings
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Others
13.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global ePharmacy Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.2. Market Revenue and Forecast, by Type (2017-2030)
14.1.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.1.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.1.5. Market Revenue and Forecast, by Platform (2017-2030)
14.1.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.1.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.1.8.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.1.8.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.1.8.5. Market Revenue and Forecast, by Platform (2017-2030)
14.1.8.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.1.8.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.1.9.5. Market Revenue and Forecast, by Platform (2017-2030)
14.1.9.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.1.9.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.2. Europe
14.2.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.2.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.2.5. Market Revenue and Forecast, by Platform (2017-2030)
14.2.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.2.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.2.8.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.2.8.5. Market Revenue and Forecast, by Platform (2017-2030)
14.2.8.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.2.8.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.9.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.2.9.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.2.9.5. Market Revenue and Forecast, by Platform (2017-2030)
14.2.9.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.2.9.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.10.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.10.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.2.10.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.2.10.5. Market Revenue and Forecast, by Platform (2017-2030)
14.2.10.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.2.10.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.2.11.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.2.11.5. Market Revenue and Forecast, by Platform (2017-2030)
14.2.11.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.2.11.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.3.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.3.5. Market Revenue and Forecast, by Platform (2017-2030)
14.3.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.3.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.8.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.3.8.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.3.8.5. Market Revenue and Forecast, by Platform (2017-2030)
14.3.8.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.3.8.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.9.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.3.9.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.3.9.5. Market Revenue and Forecast, by Platform (2017-2030)
14.3.9.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.3.9.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.3.10.5. Market Revenue and Forecast, by Platform (2017-2030)
14.3.10.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.3.10.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.11.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.11.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.3.11.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.3.11.5. Market Revenue and Forecast, by Platform (2017-2030)
14.3.11.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.3.11.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.4.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.4.5. Market Revenue and Forecast, by Platform (2017-2030)
14.4.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.4.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.8.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.4.8.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.4.8.5. Market Revenue and Forecast, by Platform (2017-2030)
14.4.8.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.4.8.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.9.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.4.9.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.4.9.5. Market Revenue and Forecast, by Platform (2017-2030)
14.4.9.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.4.9.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.4.10.5. Market Revenue and Forecast, by Platform (2017-2030)
14.4.10.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.4.10.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.11.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.11.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.4.11.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.4.11.5. Market Revenue and Forecast, by Platform (2017-2030)
14.4.11.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.4.11.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.2. Market Revenue and Forecast, by Type (2017-2030)
14.5.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.5.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.5.5. Market Revenue and Forecast, by Platform (2017-2030)
14.5.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.5.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.5.8.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.5.8.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.5.8.5. Market Revenue and Forecast, by Platform (2017-2030)
14.5.8.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.5.8.7. Market Revenue and Forecast, by Payment Method (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Drug Type (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Operating Platform (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Platform (2017-2030)
14.5.9.6. Market Revenue and Forecast, by Business Model (2017-2030)
14.5.9.7. Market Revenue and Forecast, by Payment Method (2017-2030)
Chapter 15. Company Profiles
15.1. The Kroger Co.
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. DocMorris
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Walgreen Co.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Rowlands Pharmacy
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Giant Eagle, Inc.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Optum Rx, Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Walmart, Inc.
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. CVS Health
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Express Scripts Holding Company
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Netmeds
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1793
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
